نتائج البحث - "Dominique ELIAS"

1

Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial

المساهمون: UNICANCER - Institut régional du Cancer Montpellier Val d'Aurelle (ICM), CRLCC Val d'Aurelle - Paul Lamarque, Institut Gustave Roussy (IGR), Département de chirurgie générale [Gustave Roussy], Département de chirurgie viscérale [Gustave Roussy], Hôpital Purpan [Toulouse], CHU Toulouse [Toulouse], CArcinose Péritoine Paris-Technologies (ex-CART) (CAP Paris-Tech (UMR_S_1275)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP), Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Centre Hospitalier Universitaire [Grenoble] (CHU), Centre Paul Papin, CRLCC Paul Papin, CHU Clermont-Ferrand, Centre de Recherche en Automatique de Nancy (CRAN), Centre National de la Recherche Scientifique (CNRS)-Université de Lorraine (UL), Institut de Cancérologie de Lorraine - Alexis Vautrin [Nancy] (UNICANCER/ICL), UNICANCER, CHU Tenon [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre Léon Bérard [Lyon], Institut de Cancérologie de l'Ouest [Angers/Nantes] (UNICANCER/ICO), Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL), Institut Curie [Paris], Hôpital de Hautepierre [Strasbourg], Centre Hospitalier Universitaire de Nice (CHU Nice), CCSD, Accord Elsevier, Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Hôpital du Bocage, Hôpital Hôtel-Dieu de Clermont-Ferrand, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), UNICANCER-GI Group and BIG Renape Group: Pascale Mariani, Cécile Brigand, Jean-Marc Bereder, Simon Msika, Guillaume Portier, Patrick Rat

المصدر: Lancet Oncology
Lancet Oncology, Elsevier, 2021, 22 (2), pp.256-266. ⟨10.1016/s1470-2045(20)30599-4⟩
Lancet Oncology, 2021, 22 (2), pp.256-266. ⟨10.1016/s1470-2045(20)30599-4⟩

مصطلحات موضوعية: Male, medicine.medical_specialty, Colorectal cancer, [SDV]Life Sciences [q-bio], Population, Hyperthermic Intraperitoneal Chemotherapy, Disease-Free Survival, 03 medical and health sciences, Folinic acid, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, education, Adverse effect, Peritoneal Neoplasms, education.field_of_study, Performance status, business.industry, Cytoreduction Surgical Procedures, Middle Aged, medicine.disease, Combined Modality Therapy, 3. Good health, Surgery, Oxaliplatin, [SDV] Life Sciences [q-bio], Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Peritoneal Cancer Index, 030211 gastroenterology & hepatology, Hyperthermic intraperitoneal chemotherapy, Female, Fluorouracil, France, business, Colorectal Neoplasms, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80987b365279780abb7a9593ab7f9f78Test
https://hal.archives-ouvertes.fr/hal-03220825Test

2

Peritoneal and extraperitoneal relapse after previous curative treatment of peritoneal metastases from colorectal cancer: What survival can we expect?

المؤلفون: A. Mariani, Diane Goéré, Valérie Boige, Michel Ducreux, David Malka, Dominique Elias, Maximiliano Gelli, Isabelle Sourouille, Thierry de Baere, Janina F.L. Huguenin, Léonor Benhaim

المصدر: European Journal of Cancer. 100:94-103

مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Time Factors, Adolescent, Databases, Factual, Colorectal cancer, Gastroenterology, Disease-Free Survival, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Recurrence, Risk Factors, Internal medicine, Overall survival, Humans, Medicine, Peritoneal Neoplasms, Aged, Retrospective Studies, business.industry, Proportional hazards model, Cytoreduction Surgical Procedures, Hyperthermia, Induced, Middle Aged, medicine.disease, Treatment Outcome, Oncology, Curative treatment, 030220 oncology & carcinogenesis, Retreatment, Female, 030211 gastroenterology & hepatology, Hyperthermic intraperitoneal chemotherapy, Colorectal Neoplasms, business, Cytoreductive surgery, Previously treated, Median survival

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::621e04f7b3228f646a3a494b41192ca4Test
https://doi.org/10.1016/j.ejca.2018.04.015Test

3

Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study

المساهمون: Institut Gustave Roussy (IGR), Département de chirurgie viscérale [Gustave Roussy], Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL), Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Institut du Cancer de Montpellier (ICM), Centre Régional de Lutte contre le Cancer François Baclesse [Caen] (UNICANCER/CRLC), Normandie Université (NU)-UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN), Centre de Lutte contre le Cancer Antoine Lacassagne [Nice] (UNICANCER/CAL), UNICANCER-Université Côte d'Azur (UCA), Centre Paul Papin(Angers), Institut de Cancérologie de l'Ouest [Angers/Nantes] (UNICANCER/ICO), UNICANCER, Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Service de chirurgie digestive [CHU Rouen], CHU Rouen, Normandie Université (NU)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU), Service de Chirurgie Générale, Digestive et Endocrine [CHU Reims], Centre Hospitalier Universitaire de Reims (CHU Reims), Génétique Expérimentale en Productions Animales (GEPA), Institut National de la Recherche Agronomique (INRA), Institut de Cancérologie de Lorraine - Alexis Vautrin [Nancy] (UNICANCER/ICL), Centre Hospitalier Universitaire [Grenoble] (CHU), Hôpital de Hautepierre [Strasbourg], Centre Léon Bérard [Lyon], Service de Chirurgie Digestive, Cancérologique, Générale, Endocrinienne et Urgences (CHU de Dijon), Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Service de Chirurgie digestive, endocrinienne et générale [CHU Limoges], CHU Limoges, Institut Curie [Paris], Service de Chirurgie Digestive [CHRU Besançon], Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), CHU Tenon [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Hôpital de la Timone [CHU - APHM] (TIMONE), CHU Amiens-Picardie, Simplification des soins chez les patients complexes - UR UPJV 7518 (SSPC), Université de Picardie Jules Verne (UPJV), Embedded Computing Laboratory [Gif-sur-Yvette], Commissariat à l'énergie atomique et aux énergies alternatives (CEA), Service de biostatistique et d'épidémiologie (SBE), Direction de la recherche clinique [Gustave Roussy], Institut Gustave Roussy (IGR)-Institut Gustave Roussy (IGR)

المصدر: Lancet Oncology
Lancet Oncology, 2020, 21 (9), pp.1147-1154. ⟨10.1016/S1470-2045(20)30322-3⟩

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Adolescent, Colorectal cancer, [SDV]Life Sciences [q-bio], Leucovorin, Phases of clinical research, 030230 surgery, Disease-Free Survival, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Humans, Medicine, Neoplasm Metastasis, Adverse effect, Peritoneal Neoplasms, Aged, Intention-to-treat analysis, business.industry, Hazard ratio, Hyperthermia, Induced, Middle Aged, medicine.disease, Oxaliplatin, Surgery, Irinotecan, Oncology, Second-Look Surgery, 030220 oncology & carcinogenesis, Female, Hyperthermic intraperitoneal chemotherapy, Fluorouracil, Neoplasm Recurrence, Local, Colorectal Neoplasms, business, medicine.drug